Oncology Institute (DFPH) Retained Earnings (2019 - 2026)

Oncology Institute has reported Retained Earnings for 8 years, with the latest figure at -$273.9 million in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings fell 18.89% year-over-year to -$273.9 million; the trailing twelve-month figure through Mar 2026 stood at -$273.9 million (down 18.89% YoY), and the FY2025 full-year result was -$271.4 million, down 28.75% from the prior year.
• Retained Earnings for Q1 2026 stood at -$273.9 million, down from -$271.4 million in the prior quarter.
• The five-year high for Retained Earnings was -$43.9 million in Q1 2022, with the low at -$273.9 million in Q1 2026.
• Historically, Retained Earnings has averaged -$160.5 million across 5 years, with a median of -$166.0 million in 2024.
• Annual changes were most pronounced in 2022 — Retained Earnings grew 0.24% — and 2023, when it plunged 144.64%.
• Oncology Institute's Retained Earnings stood at -$63.1 million in 2022, then slumped by 131.68% to -$146.2 million in 2023, then sank by 44.24% to -$210.8 million in 2024, then dropped by 28.75% to -$271.4 million in 2025, then fell by 0.92% to -$273.9 million in 2026.
• The last three Retained Earnings figures came in at -$273.9 million (Q1 2026), -$271.4 million (Q4 2025), and -$263.9 million (Q3 2025), per Business Quant data.